13 reports

By the year 2040, ## adult in ## will have diabetes.

  • Insulin Delivery
  • Type 1 Diabetes
  • World
  • Market Size
  • Animas Corporation

AFREZZA COMES WITH A BOXED WARNING ABOUT THE RISK OF ACUTE BRONCHOSPASM IN PATIENTS WITH ASTHMA AND CHRONIC LUNG DISEASE, WHICH MIGHT LIMIT ITS WIDESPREAD USE.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Sanofi S.A.

AFREZZA COMES WITH A BOXED WARNING ABOUT THE RISK OF ACUTE BRONCHOSPASM IN PATIENTS WITH ASTHMA AND CHRONIC LUNG DISEASE, WHICH MIGHT LIMIT ITS WIDESPREAD USE.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group

AFREZZA COMES WITH A BOXED WARNING ABOUT THE RISK OF ACUTE BRONCHOSPASM IN PATIENTS WITH ASTHMA AND CHRONIC LUNG DISEASE, WHICH MIGHT LIMIT ITS WIDESPREAD USE.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group

AFREZZA COMES WITH A BOXED WARNING ABOUT THE RISK OF ACUTE BRONCHOSPASM IN PATIENTS WITH ASTHMA AND CHRONIC LUNG DISEASE, WHICH MIGHT LIMIT ITS WIDESPREAD USE.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group

AFREZZA COMES WITH A BOXED WARNING ABOUT THE RISK OF ACUTE BRONCHOSPASM IN PATIENTS WITH ASTHMA AND CHRONIC LUNG DISEASE, WHICH MIGHT LIMIT ITS WIDESPREAD USE.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group

" QVAR has been an available asthma treatment option for well over a decade, so we are excited by the new technology of QVAR RediHaler that directly addresses an unmet need in the field of asthma management, " said Brendan O' Grady, Executive Vice President, North Ameri

  • Clinical Trial
  • Endocrine Disease
  • Insulin Delivery
  • Type 1 Diabetes
  • Medtronic, Inc.
  • Business Description
  • VENTURE FINANCING

It also performs clinical trials and tolerance assay studies in transplantation, autoimmune diseases, and allergy and asthma.

  • Diabetes
  • Healthcare
  • Pharmaceutical
  • Type 1 Diabetes
  • United States

The molecules developed by companies in Phase III, Preclinical and Discovery stages are ##, ## and ## respectively.

  • Therapy
  • Type 1 Diabetes
  • World
  • Product Initiative
  • Shenogen Pharma Group
  • PARTNERSHIPS
  • SFC FLUIDICS ENTERS INTO DEVELOPMENT PARTNERSHIP WITH JUVENILE DIABETES RESEARCH FOUNDATION

Overall, for every six mothers treated, one large birthweight baby and one neonatal intensive care unit admission were prevented.

  • Diabetes
  • Medical Device
  • Medical Equipment
  • Type 1 Diabetes
  • United States
  • Research and Development Brief
  • INV-88 - DRUG PROFILE

Centocor, Inc. initiated two Phase II trials of golimumab in treating asthma patients.

  • Chronic Disease
  • Type 1 Diabetes
  • United States
  • World
  • Company
  • TYPE 1 DIABETES (JUVENILE DIABETES) - PIPELINE BY SELECTA BIOSCIENCES, INC., H2 2016
  • TYPE 1 DIABETES (JUVENILE DIABETES) - PIPELINE BY SEMMA THERAPEUTICS INC., H2 2016

Its pharmaceutical products comprise inhaled corticosteroid for asthma, osteoporosis drugs, anti-hyperuricemia agent, and others.

  • Biotechnology
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Company
  • Product Initiative

Participants were allocated ##:##:##:## to receive daily infusions of teplizumab (full dose for ## days, ##/ ## dose for ## days, or full dose for six days) or placebo at baseline and at six months.

  • Glycoprotein
  • Type 1 Diabetes
  • World
  • Product Initiative
  • Xencor, Inc.